Skip to main content

Your search for “Melanoma” returned 45 results

Immune Cells Infiltrating Tumors May Play Bigger Cancer Role Than Previously Thought

June 22, 2020

UC San Diego researchers uncovered in mice how IRE1α, a molecule involved in cells’ response to stress, determines whether macrophages promote inflammation in the tumor microenvironment. Inflammation is known to promote tumor growth, making IRE1α an attractive target for drug development.

Poison Drummer Rikki Rockett Cancer-Free Following Immunotherapy at UC San Diego Health

July 18, 2016

Rikki Rockett, drummer for the band Poison, got the best news of his life last week: his cancer is gone. Rockett was diagnosed with oral cancer more than a year ago. Several months ago, he came to Moores Cancer Center at UC San Diego Health, where he underwent experimental cancer…

J. Silvio Gutkind, PhD, Named Chair of the Department of Pharmacology

October 6, 2020

J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at UC San Diego School of Medicine.

UC San Diego Moores Cancer Center’s J. Silvio Gutkind Joins National Academy of Medicine

October 21, 2019

J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.

UC San Diego to Partner with New Allen Institute for Immunology

December 12, 2018

UC San Diego researchers join national effort to better understand human immune system as part of new Allen Institute of Immunology.

Antibody Breaks Leukemia’s Hold, Providing New Therapeutic Approach

October 27, 2016

Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores Cancer Center discovered that a cell surface molecule known as CD98 promotes AML. The study also…

Mapping Mutation ‘Hotspots’ in Cancer Reveals New Drivers and Biomarkers

February 9, 2022

UC San Diego researchers have identified a previously unrecognized key player in cancer evolution: clusters of mutations occurring at certain regions of the genome. These mutation clusters contribute to the progression of about 10% of human cancers and can be used to predict patient survival.

Researchers Find a New Way to Identify and Target Malignant Aging in Leukemia

August 26, 2016

Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and leukemia stem cells associated with secondary acute myeloid leukemia (sAML), a particularly problematic disease that typically afflicts older patients who have often already…

In Cells, UV-Emitting Nail Polish Dryers Damage DNA and Cause Mutations

January 17, 2023

The ultraviolet nail polish drying devices used to cure gel manicures may pose more of a public health concern than previously thought. Researchers at UC San Diego studied these UV light-emitting devices, and found that their use leads to cell death and cancer-causing mutations in human cells.

Why Young and Female Patients Don’t Respond as Well to Cancer Immunotherapy

August 17, 2020

UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance.

Category navigation with Social links